2026 Global: Bone Marrow Biopsy Needles Market -Competitive Review (2032) report
Description
The 2026 Global: Bone Marrow Biopsy Needles Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bone marrow biopsy needles market by geography and historical trend. The scope of the report extends to sizing of the bone marrow biopsy needles market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The bone marrow biopsy needles market is dominated by ten major companies, led by Becton, Dickinson and Company (BD), Stryker Corporation, and Merit Medical Systems, which collectively hold significant market shares due to innovative products like BD's Jamshidi™ and TruCore® systems, Stryker's OsteoScoop2 and OnControl® devices, and Merit Medical's QuikCore™ system. Argon Medical Devices ranks prominently with its T-Lok™ needles, featuring unique cannula designs for high-quality specimens and ergonomic handles that reduce clinician discomfort, alongside partnerships like Terumo India for expanded distribution. Cardinal Health contributes through minimally invasive biopsy devices, including bone marrow aspiration needles, bolstered by a robust global supply chain and strategic acquisitions enhancing accessibility in oncology diagnostics. These leaders emphasize precision, patient comfort, and procedural efficiency, capturing 18-22% for BD, 15-19% for Stryker, 12-16% for Merit, 10-14% for Argon, and 8-12% for Cardinal Health in bone biopsy systems.
Medtronic, Cook Medical, and Teleflex Incorporated form the next tier, with Medtronic offering ergonomic marrow biopsy needles for oncology and orthopedics, Cook providing specialized Jamshidi-style needles for hematology with minimal patient discomfort, and Teleflex focusing on advanced disposable systems. Emerging players like Shandong Weigao Medical and Qingdao Hiprove Medical from China challenge globals through high-volume production and exports; Weigao excels in OEM scalability for global markets, while Hiprove specializes in Tru-Cut bone marrow kits for Europe, Middle East, and Africa. Vertical integration in Chinese firms like Nanchang Kindly Group enables cost-effective stainless steel needles for biopsy and aspiration, supporting mid-to-high volume clinical needs with ISO certifications. These companies drive market growth via R&D investments, with North America leading due to high procedure volumes.
Innovation and regional expansion define competition, as seen in BD's TruGuide™ integration for safety, Stryker's power-assisted systems reducing procedure time, and Argon's EchoTip™ with CE marking for emerging markets. Chinese manufacturers like Lepu Medical/Lifetech and EikoMed gain traction through customization, precision CNC machining, and flexible MOQs for OEMs in Asia, EU, and US, often at lower costs. Overall, the market favors disposable, ergonomic needles amid rising hematology and cancer diagnostics, with leaders like Medtronic and Cook fortifying positions via acquisitions and minimally invasive tech. This dynamic fosters a projected CAGR of over 5% through 2035, prioritizing sample integrity and clinician ease.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bone marrow biopsy needles market by geography and historical trend. The scope of the report extends to sizing of the bone marrow biopsy needles market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The bone marrow biopsy needles market is dominated by ten major companies, led by Becton, Dickinson and Company (BD), Stryker Corporation, and Merit Medical Systems, which collectively hold significant market shares due to innovative products like BD's Jamshidi™ and TruCore® systems, Stryker's OsteoScoop2 and OnControl® devices, and Merit Medical's QuikCore™ system. Argon Medical Devices ranks prominently with its T-Lok™ needles, featuring unique cannula designs for high-quality specimens and ergonomic handles that reduce clinician discomfort, alongside partnerships like Terumo India for expanded distribution. Cardinal Health contributes through minimally invasive biopsy devices, including bone marrow aspiration needles, bolstered by a robust global supply chain and strategic acquisitions enhancing accessibility in oncology diagnostics. These leaders emphasize precision, patient comfort, and procedural efficiency, capturing 18-22% for BD, 15-19% for Stryker, 12-16% for Merit, 10-14% for Argon, and 8-12% for Cardinal Health in bone biopsy systems.
Medtronic, Cook Medical, and Teleflex Incorporated form the next tier, with Medtronic offering ergonomic marrow biopsy needles for oncology and orthopedics, Cook providing specialized Jamshidi-style needles for hematology with minimal patient discomfort, and Teleflex focusing on advanced disposable systems. Emerging players like Shandong Weigao Medical and Qingdao Hiprove Medical from China challenge globals through high-volume production and exports; Weigao excels in OEM scalability for global markets, while Hiprove specializes in Tru-Cut bone marrow kits for Europe, Middle East, and Africa. Vertical integration in Chinese firms like Nanchang Kindly Group enables cost-effective stainless steel needles for biopsy and aspiration, supporting mid-to-high volume clinical needs with ISO certifications. These companies drive market growth via R&D investments, with North America leading due to high procedure volumes.
Innovation and regional expansion define competition, as seen in BD's TruGuide™ integration for safety, Stryker's power-assisted systems reducing procedure time, and Argon's EchoTip™ with CE marking for emerging markets. Chinese manufacturers like Lepu Medical/Lifetech and EikoMed gain traction through customization, precision CNC machining, and flexible MOQs for OEMs in Asia, EU, and US, often at lower costs. Overall, the market favors disposable, ergonomic needles amid rising hematology and cancer diagnostics, with leaders like Medtronic and Cook fortifying positions via acquisitions and minimally invasive tech. This dynamic fosters a projected CAGR of over 5% through 2035, prioritizing sample integrity and clinician ease.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
